Dr. Reddy's Laboratories Ltd receives EIR from USFDA for IPDO facility

Dr. Reddy's Laboratories Ltd had earlier announced about the audit of its Integrated Product Development Organization (IPDO) at Medchal-Malkajgiri, Telangana. The company has received the Establishment Inspection Report (EIR) from US FDA, for the above-referred facility, indicating closure of the audit and the inspection classification of this facility is determined as "No Action Indicated" (NAI).

Shares of DR.REDDY's LABORATORIES LTD. was last trading in BSE at Rs.3883.3 as compared to the previous close of Rs. 3863.65. The total number of shares traded during the day was 49668 in over 3592 trades.

The stock hit an intraday high of Rs. 3900 and intraday low of 3815.6. The net turnover during the day was Rs. 190984248.

Source : Equity Bulls

Keywords